scholarly journals Minimally Invasive Treatments for Liver Cancer

10.5772/65107 ◽  
2017 ◽  
Author(s):  
Nicolas Cardenas ◽  
Rahul Sheth ◽  
Joshua Kuban
Keyword(s):  
Liver Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Treatments

scholarly journals Five-Year Results of Radiofrequency and Laser Ablation of Benign Thyroid Nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group

Thyroid ◽  
2020 ◽  
Vol 30 (12) ◽  
pp. 1759-1770 ◽  
Author(s):  
Stella Bernardi ◽  
Fabiola Giudici ◽  
Roberto Cesareo ◽  
Giovanni Antonelli ◽  
Marco Cavallaro ◽  
...  
Keyword(s):  
Laser Ablation ◽  
Minimally Invasive ◽  
Multicenter Study ◽  
Thyroid Nodules ◽  
Benign Thyroid Nodules ◽  
Benign Thyroid ◽  
Minimally Invasive Treatments

scholarly journals European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions

2021 ◽  
pp. 1-13
Author(s):  
Giovanni Mauri ◽  
Laszlo Hegedüs ◽  
Steven Bandula ◽  
Roberto Luigi Cazzato ◽  
Agnieszka Czarniecka ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Neck Dissection ◽  
Surgical Complications ◽  
High Intensity Focused Ultrasound ◽  
External Beam Radiation ◽  
Cervical Lymph Nodes ◽  
Beam Radiation ◽  
Surgical Risk ◽  
Radiological Society ◽  
Minimally Invasive Treatments

The growing detection of papillary thyroid microcarcinomas (PTMCs) is paralleled by an increase in surgical procedures. Due to the frequent indolent nature, cost, and risk of surgery, active surveillance (AS) and ultrasound-guided minimally invasive treatments (MITs) are in suitable cases of incidental PTMC proposed as alternatives to thyroidectomy. Surgery and radioiodine are the established treatments for relapsing cervical differentiated thyroid carcinoma (DTC) metastases. But radioiodine refractoriness, risk of surgical complications, adverse influence on quality of life, or declining repeat surgery have led to AS and MIT being considered as alternatives for slow-growing DTC nodal metastases. Also, for distant radioiodine-refractory metastases not amenable to surgery, MIT is proposed as part of a multimodality therapeutic approach. The European Thyroid Association and the Cardiovascular and Interventional Radiological Society of Europe commissioned these guidelines for the appropriate use of MIT. Based on a systematic PubMed search, an evidence-based approach was applied, and both knowledge and practical experience of the panelists were incorporated to develop the manuscript and the specific recommendations. We recommend that when weighing between surgery, radioiodine, AS, or MIT for DTC, a multidisciplinary team including members with expertise in interventional radiology assess the demographic, clinical, histological, and imaging characteristics for appropriate selection of patients eligible for MIT. Consider TA in low-risk PTMC patients who are at surgical risk, have short life expectancy, relevant comorbidities, or are unwilling to undergo surgery or AS. As laser ablation, radiofrequency ablation, and microwave ablation are similarly safe and effective thermal ablation (TA) techniques, the choice should be based on the specific competences and resources of the centers. Use of ethanol ablation and high-intensity focused ultrasound is not recommended for PTMC treatment. Consider MIT as an alternative to surgical neck dissection in patients with radioiodine refractory cervical recurrences who are at surgical risk or decline further surgery. Factors that favor MIT are previous neck dissection, presence of surgical complications, small size metastases, and <4 involved latero-cervical lymph nodes. Consider TA among treatment options in patients with unresectable oligometastatic or oligoprogressive distant metastases to achieve local tumor control or pain palliation. Consider TA, in combination with bone consolidation and external beam radiation therapy, as a treatment option for painful bone metastases not amenable to other established treatments.

New Approaches to the Minimally Invasive Treatment of Liver Cancer

2005 ◽  
Vol 11 (1) ◽  
pp. 52-56 ◽  
Author(s):  
Fumihiko Fujita ◽  
Rie Fujita ◽  
Takashi Kanematsu
Keyword(s):  
Liver Cancer ◽  
Minimally Invasive ◽  
Minimally Invasive Treatment ◽  
Invasive Treatment ◽  
New Approaches

scholarly journals Possibilities of minimally invasive treatments of hemorrhoidal disease

2018 ◽  
pp. 77-82 ◽  
Author(s):  
M. V. Abritsova
Keyword(s):  
Surgical Treatment ◽  
Minimally Invasive ◽  
Postoperative Period ◽  
Harmonic Scalpel ◽  
Hemorrhoidal Disease ◽  
Single Center ◽  
Narcotic Analgesics ◽  
Group I ◽  
Minimally Invasive Treatments ◽  
Observation Period

The article presents the results of surgical treatment of patients with stages III to IV hemorrhoids followed by an observation period of 45 days, which is designed to improve the results of surgical treatment of this category of patients. The surgical treatment methods included doppler-guided transanal hemorrhoiddearterialization with mucopexy (DDM) (Group I) and harmonic scalpel hemorrhoidectomy (HSH) (Group II). Operated patients underwent all necessary examinations according to the “per protocol” principle. Study Design: single-center controlled randomized prospective. The effectiveness of DDM was comparable to that of hemorrhoidectomy (HE), which made it possible to significantly reduce the duration of the operation (DDM 17.9 ± 6.1 min, GE 34.5 ± 10.1 min (p <0.01) ), reduce the level of pain in the postoperative period (DDM an average of 2.5 points, HE 4.8 points (p <0.01)), reduce the frequency of narcotic analgesics (DDM an average of 1.3 doses, HE an average of 6.1 doses (p <0.01)) and shorten the period of disability (DDM 14.4 ± 5.2 days, HE 30.3 ± 5.4 days (p <0.01)) patients with stages III to IV disease.

Sign in / Sign up

Export Citation Format

Share Document